71 FR 190 pgs. 57983-57984 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Type: NOTICEVolume: 71Number: 190Pages: 57983 - 57984
FR document: [FR Doc. 06-8407 Filed 9-29-06; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Clinical Laboratory Diagnostics for Invasive Aspergillosis.
Date: October 16, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alec Ritchie, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID/DHHS, 6700 B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-435-1614; aritchie@niaid.nih.gov.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Development of Therapeutic Agents for Selected Biodefense Bacterial Diseases.
Date: October 19-20, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Holiday Inn Capitol, 550 C Street, SW., Washington, DC 20024.
Contact Person: Stefani T. Rudnick, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2550, srudnick@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Role of Antibodies and Dendritic Cells in Autoimmune Disease Progression or Tolerance Induction.
Date: October 19, 2006.
Time: 9:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Mercy R. Prabhudas, Phd., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2615, mp457n@nih.gov.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Teleconference Review of an Intracellular Pathogen Program Application.
Date: October 25, 2006.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3118, Bethesda, Md 20817, (Telephone Conference Call).
Contact Person: Quirijn Vos, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-451-2666, qvos@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: September 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8407 Filed 9-29-06; 8:45 am]
BILLING CODE 4140-01-M